Australia markets closed

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.30+0.29 (+2.63%)
At close: 04:00PM EDT
11.29 -0.01 (-0.09%)
Pre-market: 09:13AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.01
Open10.87
Bid11.29 x 4800
Ask11.32 x 13000
Day's range10.80 - 11.32
52-week range10.69 - 31.32
Volume21,818,367
Avg. volume18,014,008
Market cap9.755B
Beta (5Y monthly)0.70
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.00 (8.85%)
Ex-dividend date21 Aug 2024
1y target estN/A
  • Business Wire

    Walgreens Receives BARDA Project NextGen Award to Conduct Novel COVID-19 Decentralized Clinical Study

    DEERFIELD, Ill., July 23, 2024--Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will be protected from future infections, using COVID-19 vaccine data. The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Au

  • Business Wire

    Walgreens Introduces Nice! For You to Help Customers Make Healthier Food and Beverage Choices

    DEERFIELD, Ill., July 16, 2024--Walgreens, the leading integrated independent retail pharmacy and healthcare provider, is launching Nice! For You, a new tier of its popular owned grocery brand, Nice!, to help customers find food choices that help support their journey to a healthier lifestyle. Nice! launched in 2011 and offers a range of everyday food and beverage products at an incredible value.

  • Business Wire

    Walgreens Boots Alliance Appoints William H. Shrank, M.D., to Board of Directors

    DEERFIELD, Ill., July 10, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of William H. Shrank, M.D., to the company’s board of directors. Dr. Shrank is globally recognized for his leadership and expertise in healthcare strategy, policy and population health. He joins the WBA board at an important time as the company strengthens its business.